Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing genetic diversity and health inequities: RELIVAF's proposal for Latin American pharmacogenomic guidelines.

Frontiers in pharmacology·2026
Same author

Association of toll-like receptors polymorphisms with atopy and asthma symptoms in Latin American children.

Cytokine·2025
Same author

Uncovering genetic mechanisms associated with harmful use of alcohol in admixed Latin Americans.

BMC genomics·2025
Same author

Ethnopharmacological investigations on the cardiometabolic protective effects of Caiman yacare fat oil in hypertensive and dyslipidemic rats.

Journal of ethnopharmacology·2025
Same author

Follicular cell-derived thyroid carcinomas harboring novel genetic <i>BRAF</i> mutations: real-world data obtained using a multigene panel.

Archives of endocrinology and metabolism·2024
Same author

Genome-wide association study of Helicobacter pylori serological status in Latin American children.

Helicobacter·2023

Related Experiment Video

Updated: May 31, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Is the GSTM1 null polymorphism a risk factor in primary open angle glaucoma?

Auta Viviane Rocha1, Teddy Talbot, Thiago Magalhães da Silva

  • 1Universidade Estadual de Santa Cruz, Departamento de Ciências da Saúde, Laboratório de Farmacogenômica e Epidemiologia Molecular, Ilhéus, Bahia, Brazil.

Molecular Vision
|July 9, 2011
PubMed
Summary

Glutathione S-transferase (GST) gene variations, particularly the GSTM1 null polymorphism, are linked to an increased risk of primary open angle glaucoma (POAG). These genetic factors also correlate with more severe disease characteristics in the Brazilian population.

Related Experiment Videos

Last Updated: May 31, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Primary open angle glaucoma (POAG) is a leading cause of irreversible blindness worldwide.
  • Glutathione S-transferases (GSTs) are crucial enzymes involved in detoxification and cellular protection.
  • Genetic polymorphisms in GST genes may influence susceptibility to complex diseases like POAG.

Purpose of the Study:

  • To investigate the association between polymorphisms in glutathione S-transferase (GST) genes (GSTM1, GSTT1, GSTP1) and the risk of primary open angle glaucoma (POAG).
  • To explore the relationship between these GST gene polymorphisms and the clinical features of POAG.

Main Methods:

  • A case-control study was conducted with 87 Brazilian POAG patients and 85 healthy controls.
  • Blood samples were analyzed for polymorphisms in GSTM1, GSTT1, and GSTP1 genes using polymerase chain reaction (PCR) methods.
  • Genotypes were compared between POAG patients and controls, and associations with clinical parameters were assessed.

Main Results:

  • The GSTM1 null polymorphism was significantly more prevalent in POAG patients compared to controls (OR: 2.1).
  • Combined genotypes (GSTM1 null/GSTT1+ and GSTM1 null/GSTP1 Ile/Val or Val/Val) were associated with an increased risk of POAG.
  • Specific GST genotypes correlated with higher intraocular pressure (IOP) and more severe optic nerve and visual field defects.

Conclusions:

  • The GSTM1 null polymorphism is a significant risk factor for POAG in the Brazilian population.
  • GST gene polymorphisms may influence POAG pathogenesis and disease severity.
  • Further research is warranted to elucidate the role of GSTs in glaucoma development.